Plato Investment Management Ltd
Position in NBIX — Neurocrine Biosciences Inc
CIK 1984475
SYDNEY, C3
Position in NBIX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$675,171
+$150,715 QoQ
Shares Held
4,006
+0.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#438
of 768 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Plato Investment Management Ltd holds $2,763,293 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (24.4% of the industry book) .
All Filings in NBIX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $675,171 | 4,006 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $524,456 | 3,981 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $564,625 | 3,981 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $324,137 | 2,309 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $286,824 | 2,282 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $252,389 | 2,282 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $1,480,206 | 10,844 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,264,309 | 10,973 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $58,509 | 425 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $40,686 | 295 | Shares | Sole | 2024-05-17 | |
| No filing history on record for this holder in this stock. | ||||||